Hypomagnesaemia/hypokalemia associated with the use of esomeprazole

Current Drug Safety

Volumn 6, Issue 3, 2011, Pages 204-206

  Negri, Armando L ^a   del Valle, Elisa E ^a  

^a UNIVERSIDAD DEL SALVADOR   (Argentina)

Author keywords

Esomeprazole; Hypokalemia; Hypomagnesaemia; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; MAGNESIUM; POTASSIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL 7;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; HOMEOSTASIS; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; IRRITABILITY; KALIURESIS; MALE; POTASSIUM EXCRETION; PRIORITY JOURNAL; RECURRENCE RISK; URINARY EXCRETION;

ANTI-ULCER AGENTS; HUMANS; HYPOKALEMIA; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMP INHIBITORS;

EID: 80054115001     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488611797579320     Document Type: Article

References (27)

1. Naderi AS, Reilly RF jr. Hereditary etiologies of hypomagnesaemia. Nat Clin Pract Nephrol 2008; 4(2) 80-9.
2. Ferment O, Garnier PE, Touitou Y. Comparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man. J Endocrinol 1987; 113: 117-22.
3. Cholst IN, Steinberg SF, Tropper PJ, Fox HE, Segre GV, Bilezikian JP. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984; 310(19): 1221-5.
4. Konrad M, Schlingmann KP, Gudermann T. Insights into the molecular nature of magnesium homeostasis. Am. J Physiol Renal Physiol 2004; 286: F599-F605.
5. Cundy T, Dissayake A. Severe hypomagnesaemia in long term users of proton-pump inhibitors. Clin Endocrinol (Oxf) 2008; 69(2): 338-41
6. Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 2006; 26: 355(17): 1834-6.
7. Shabejee N, Lamb EJ, Sturgess I, Sumathipala RW. Omeprazole and refractory hypomagnesaemia. BMJ 2008; 10: 337: a425.
8. Kuipers MT, Thang HD, Arntzenius AB. Hypomagnesemia due to use of proton pump inhibitors - a review. Netherlands J Med 2009; 67(5): 169-72.
9. Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zietse R. A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis 2010; 56(1): 112-6
10. Agus ZS. Hypomagnesaemia. J Am Soc Nephrol 1999; 10: 1616-22.
11. Zaloga GP, Chernow B, Pock A, Wood B, Zaritsty A Zucker A. Hypomagnesaemia is a common complication of aminoglycoside therapy. Surg Gynecol Obstet 1984; 158: 561-5.
12. June CH, Thompson CB, Lkennedy MS, Nims J, Thomas ED. Profound hypomagnesaemia and renal magnesium wasting associated with the use of cyclosporine for bone marrow transplantation. Transplantation 1985; 39: 620-4.
13. Lajer H, Daugaard G. Cisplatin and hypomagnesaemia. Cancer Treat Rev 1999; 25(1): 47-58.
14. 2+ transport function of Claudin-16. J Clin Invest 2006; 116: 878-91.
15. Schlingmann KP, Weber S, Peters M, et al. Hypomagnesaemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002; 31(2): 166-70.
16. +-ATPase gamma-subunit. Ann N Y Acad Sci 2003; 986: 437-43.
17. Groenestege WM, Thébault S, van der Wijst J, et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesaemia. J Clin Invest 2007; 117(8): 2260-7.
18. Naranjo CA, Busto A, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
19. Mackay JD, Bladon PT. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series. Q J Med 2010; 103: 387-95.
20. Cundy T, Mackay JD. Proton pump inhibitors and severe hypomagnesaemia. Curr Opin Gastroenterol 2011; 27: 180-185.
21. Alexander RT, Hoenderop JG, Bindels RJ. Molecular determinants of magnesium homeostasis: insights from human disease. J Am Soc Nephrol 2008; 19(8): 1451-8.
22. Quamme GA. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol 2008; 24(2): 230-5.
23. Li M, Jiang J, Yue L. Functional charaecterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J Gen Physiol 2006; 127(5): 525-37.
24. 2+ permeability and pH sensitivity in TRPM6 and TRPM7. J Biol Chem.2007; 282(35): 25817-30.
25. + channel. Nature 1994; 371: 243-6.
26. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 2007; 18: 2649-52.
27. Yang L, Frindt G, Palmer LG. Magnesium modulates ROMK channelmediated potassium secretion. J Am Soc Nephrol 2010; 21: 2109-16.